Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-107607·IMMUNIC, INC.
Schedule 13G ownership disclosure
Immunic Inc
Common Stock, par value $0.0001 per share · CUSIP: 4525EP101
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Soleus Private Equity Fund III, L.P.
Shares: 1,060,457.00 · Class: 1.1%
- Soleus Private Equity GP III, LLC
Shares: 1,060,457.00 · Class: 1.1%
- Soleus PE GP III, LLC
Shares: 1,060,457.00 · Class: 1.1%
- Soleus Capital Master Fund, L.P.
Shares: 519,550.00 · Class: 0.5%
- Soleus Capital, LLC
Shares: 519,550.00 · Class: 0.5%
- Soleus Capital Group, LLC
Shares: 519,550.00 · Class: 0.5%
- Soleus Capital Management, L.P.
Shares: 1,580,007.00 · Class: 1.6%
- Soleus GP, LLC
Shares: 1,580,007.00 · Class: 1.6%
- Guy Levy
Shares: 1,580,007.00 · Class: 1.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-107607
- Form type
- SCHEDULE 13G/A
- Filer
- IMMUNIC, INC.
- CIK
- CIK 1280776
- Filed
- Nov 07, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership